Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000377578 | SCV000342774 | uncertain significance | not provided | 2016-06-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001469451 | SCV001673531 | likely benign | Duchenne muscular dystrophy | 2023-09-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004992162 | SCV005566494 | likely benign | Cardiovascular phenotype | 2024-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828253 | SCV002077635 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2021-06-21 | no assertion criteria provided | clinical testing |